All relevant data are within the paper and its Supporting Information files.

Introduction {#sec001}
============

*Acinetobacter baumannii* causes severe nosocomial infections in critically ill patients and is involved in many hospital outbreaks world-wide. It colonizes skin and mucous membranes including the gastrointestinal tract \[[@pone.0230976.ref001],[@pone.0230976.ref002]\]. This organism has the propensity for acquiring multiple resistance genes with phenotypic expression of multidrug-resistant (MDR) characteristics. MDR strains are now endemic in many hospitals around the world, including hospitals in Kuwait \[[@pone.0230976.ref003],[@pone.0230976.ref004]\]. Choosing appropriate molecular typing methods is vital for investigating epidemiological lineages of the isolates and for infection control. Numerous molecular typing methods are available including pulsed-field gel electrophoresis (PFGE) \[[@pone.0230976.ref005]\], random amplified polymorphic DNA (RAPD) analysis \[[@pone.0230976.ref006]\], ribotyping \[[@pone.0230976.ref007]\], multilocus PCR and electrospray ionization mass spectrometry (PCR/ESI-MS) \[[@pone.0230976.ref008]\], amplified fragment length polymorphism (AFLP) analysis \[[@pone.0230976.ref007]\], repetitive extragenic palindromic sequence-based PCR (rep-PCR) \[[@pone.0230976.ref009]\], and infrequent-restriction-site analysis \[[@pone.0230976.ref010]\]. PFGE is used as a common method for typing *A*. *baumannii* isolates \[[@pone.0230976.ref011]\]. Even though PFGE has a high discriminatory power, it cannot be used for comparison of data among laboratories because of technical variations \[[@pone.0230976.ref012], [@pone.0230976.ref013]\]. *A*. *baumannii* has a unique *bla*~OXA-51-like~ gene that may be used for species identification and PCR-based typing into sequence groups (SGs) \[[@pone.0230976.ref014]\]. Multilocus sequence typing (MLST), has been used successfully for global comparison of isolates \[[@pone.0230976.ref015],[@pone.0230976.ref016]\]. eBURST is used to compare the relatedness of isolates by a single locus difference as PFGE compares the isolates by the size of the restricted segments of DNA. In eBURST analysis, the relationship of isolates is presented graphically \[[@pone.0230976.ref017]\]. Whole-genome sequencing (WGS) has been used recently for epidemiological investigations \[[@pone.0230976.ref018]\]. Even though, it is more discriminatory than other methods, the technology is complex and expensive and not amenable to many laboratories \[[@pone.0230976.ref019]\].

In the adult intensive care unit (ICU) of the Mubarak Al Kabeer Hospital, which is a tertiary teaching hospital in Kuwait, there have been several outbreaks of MDR *A*. *baumannii* infection \[[@pone.0230976.ref004],[@pone.0230976.ref020]\]. The outbreak isolates were found to be multiple clones that were on many occasions not similar or related when typed by PFGE. Also, patient and hospital environmental isolates were not related. Endemic strains from ICUs without outbreaks also exhibited polyclonality \[[@pone.0230976.ref004]\]. Hence, we hypothesized that the patient gut environment may contribute to the origin of genetic diversity of these isolates, where the isolates may undergo acquisition or loss of specific mobile gene elements or recombination events under the selection pressure of antibiotic exposure during the prolonged hospital stay of patients. *A*. *baumannii* has a highly plastic genome with the resultant gain or loss of genetic materials \[[@pone.0230976.ref021]\]. Therefore, we studied the genetic relatedness of serial *A*. *baumannii* isolates colonizing the rectum of adult ICU patients at Mubarak Al Kabeer Hospital. We typed the isolates by the commonly available PFGE, MLST and eBURST methods to determine whether these methods will give sufficient insights into the evolution of colonizing strains.

Methodology {#sec002}
===========

Patients and study design {#sec003}
-------------------------

This study was carried out in the adult ICU of Mubarak Al Kabeer Hospital, Kuwait. The hospital has a total of 850 beds including 30 beds in the adult ICU. The catchment area for this hospital covers a population of approximately 800,000 people. The period of study was from March 2015 to June 2016. Rectal swabs were collected from newly admitted patients on the day of admission, third day after admission and then twice weekly until the patient was either discharged or dead. Patients who had five or more positive cultures on different days were included in the final analysis. Relevant information such as age, gender, nationality, diagnosis and comorbidity, antibiotic therapy, previous hospital admission, and live discharge or death, were carefully recorded.

Isolation and identification {#sec004}
----------------------------

The rectal swabs were inoculated into an enrichment broth containing acetate and incubated aerobically at 37°C for 48 h \[[@pone.0230976.ref022]\]. The enriched culture was subcultured onto *Acinetobacter* CHROMagar (CHROMagar, Paris, France) and incubated at 37°C for 48 h. Different morphotypes of typical large red colonies were selected for further identification by API NE20 (bioMérieux, I'Etoile, Marcy, France) and confirmed by a duplex PCR assay for *gyrB* gene according to Higgins et al 2007 \[[@pone.0230976.ref023]\].

Antibiotic susceptibility testing {#sec005}
---------------------------------

Antibiotic susceptibility testing of the isolates was performed by E-test method (bioMerieux) and interpreted according to Clinical and Laboratory Standards Institute (CLSI) susceptibility criteria \[[@pone.0230976.ref024]\]. Susceptibility to tigecycline was determined according to the criteria of Talaga et al \[[@pone.0230976.ref025]\]. Susceptibility to colistin was performed by agar dilution method and interpreted by the CLSI criteria \[[@pone.0230976.ref024]\].

Typing by DiversiLab {#sec006}
--------------------

To determine how many colonies from a patient culture plate should be analyzed, we hypothesized that there are different colony morphotypes of *A*. *baumannii* on CHROMagar and each colony morphotype represented a different genetic type. To test this hypothesis, in a preliminary pilot study, we tested colonies from 12 patients. The isolates were typed by repetitive sequence-based PCR (DiversiLab^TM^ System; bioMérieux). Clonal relatedness was analyzed with the DiversiLab software using the Pearson correlation statistical method. Relatedness was defined as: ≥98% similarity as identical, ≥ 95% and \<98% similarities as related, and \<95% similarity as unrelated.

Typing by pulsed field-gel electrophoresis (PFGE) {#sec007}
-------------------------------------------------

PFGE was performed as previously described by Seifert et al 2005 with *Apa*I restriction enzyme. \[[@pone.0230976.ref026]\]. The apparatus and conditions as \[[@pone.0230976.ref027]\]. Strain relatedness was analyzed by BioNumerics software (Applied Maths, bioMérieux). The percentage of similarity was calculated by dice coefficient with 1.5% tolerance and 1.5% optimization with a cutoff point of 100% for identical, ≥80% related and \<80% unrelated isolates \[[@pone.0230976.ref028],[@pone.0230976.ref029]\]. Major pulsotypes were represented by different clades. Isolates within the same clades were denoted as subtypes if they exhibited ≥80% and \< 100% relatedness. Strain relatedness as identical, related and unrelated was also determined manually by the criteria of Tenover et al \[[@pone.0230976.ref029]\].

Patients were given alphabetical identification and the serial isolates from a patient were denoted by the patient alphabet and a number representing the sampling number. For example, serial isolates of patient A were denoted as A1, A2, A3, etc. The relatedness of subsequent isolates to the first isolate was indicated as identical (I), related (R), or unrelated (U). If more than one colony morphotypes were studied, the morphotypes were denoted by lower case alphabets. For example, A5a and A5b, meant that on the 5^th^ sampling of patient A, there were two colony morphotypes, a and b.

Grouping of patients based on PFGE {#sec008}
----------------------------------

Based on PFGE typing of serial isolates, patients were grouped based on appearance and disappearance of various PFGE types ([Table 1](#pone.0230976.t001){ref-type="table"}). This analysis segregated patients into 4 groups. Serial isolates from one or more patients representing each group was further studied as outlined below.

10.1371/journal.pone.0230976.t001

###### Grouping pattern of 270 isolates from 32 patients by PFGE.

![](pone.0230976.t001){#pone.0230976.t001g}

  Group   Relatedness of isolates                                       Patient ~(number\ of\ isolates)~
  ------- ------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------
  **1**   Colonization with identical and related isolates              E~(7)~, Q~(5)~, Y~(6)~
  **2**   Colonization with identical, related and unrelated isolates   A~(6)~, C~(8)~, F~(5)~, K~(6)~, L~(12)~, M~(10)~, N~(13)~, P~(8)~, R~(8)~, S~(8)~, U~(5)~, W~(9)~, Z~(12),~ AA~(10)~, AB~(12),~ AD~(8),~ AF~(6)~,
  **3**   Colonization with related and unrelated isolates              B~(7)~, D~(7)~, G~(9)~, H~(6)~, O~(6)~, T~(7)~, V~(5)~
  **4**   Colonization by unrelated isolates                            I~(12)~, J~(16)~, X~(11)~, AC~(8),~ AE~(12)~

Multi-locus sequence typing (MLST) {#sec009}
----------------------------------

MLST was performed as described previously by Bartual et al, 2005 \[[@pone.0230976.ref030]\] for the Oxford theme. The final purified product was sequenced in a sequencing machine (3130xl Genetic analyzer, Applied BioSystems, CA, United States). Sequences were trimmed to the required lengths and compared by Clustal X and the sequence type determined on the website <https://pubmlst.org/abaumannii/> \[[@pone.0230976.ref031]\].

Whole genome sequencing (WGS) {#sec010}
-----------------------------

Sequencing libraries were prepared using the Nextera XT DNA sample preparation kit (Illumina, San Diego, CA, USA) and the sequence read data were produced on the Illumina NextSeq instrument (paired end, 150 base reads). De novo assembly of the read data of the isolate was performed using MegaHit \[[@pone.0230976.ref032]\]. The resulting draft genome sequence was used to derive MLST (PubMLST: <https://pubmlst.org/> for Oxford scheme).

Only the isolate K5 was subjected to WGS because the sequence of *gpi* gene for MLST could not be determined due to lack of priming of the forward primer (See under RESULTS, [S3 Fig](#pone.0230976.s006){ref-type="supplementary-material"} and [S3 Table](#pone.0230976.s003){ref-type="supplementary-material"}).

eBURST analysis {#sec011}
---------------

eBURST was used to analyze the MLST data to determine the evolutionary relationships among the isolates. The eBURST diagram was constructed by version 3.0 software (<http://eburst.mlst.net/>), using all available data from the *A*. *baumannii* PubMLST database. A complete MLST database was visualized as a single eBURST diagram.

Ethics statement {#sec012}
----------------

The ethical approval for this study was granted by the Ethics Committee, Ministry of Health, State of Kuwait (approval number 112). All patients voluntarily gave written informed consent for rectal swab collection and data collection.

Results {#sec013}
=======

Comparison of colony morphotypes with DiversiLab types {#sec014}
------------------------------------------------------

The results of the analysis on 12 patients are shown in [S1 Table](#pone.0230976.s001){ref-type="supplementary-material"} and sample DiversiLab dendrograms in [S1 Fig](#pone.0230976.s004){ref-type="supplementary-material"}. Studies of three different colonies from five patients (nos. 1, 5, 7, 9, 10) showing a single morphotype revealed that all three colonies were identical by DiversiLab. On the other hand, when colonies of different morphotypes were studied from the remaining seven patients, the colonies were either related or unrelated, but not identical. Based on this observation, single colonies representing each morphotype were studied from the patients from whom serial rectal samples were analyzed.

Study of patients with serial rectal swab collection {#sec015}
----------------------------------------------------

A total of 493 patients were studied over a period of 16 months (from March 2015 to June 2016) from whom 1912 rectal swab specimens were collected. Of these, 117 (23.7%) patients and 475 (24.8%) swabs were positive with red colonies resembling *Acinetobacter* spp. on *Acinetobacter* CHROMAgar. The isolates were then confirmed as *A*. *baumannii* by *bla*~*gyrB*~ PCR assays. Seventy-three (62.4%) patients were colonized after 72 h of admission, and 44 patients (37.6%) were colonized on the day of admission. The latter were regarded as colonization before admission to the ICU and therefore omitted from the analysis because we did not know the colonization history of already colonized patients. Of the 73 patients who acquired the isolates in the ICU, 32 (43.8%) were colonized on multiple occasions (≥5 times) yielding a total of 270 isolates.

Antibiogram of isolates {#sec016}
-----------------------

The antibiotic resistance data are shown in [S2 Table](#pone.0230976.s002){ref-type="supplementary-material"}. Most of the isolates, 89 (82.4%), were multidrug-resistant (MDR) (resistant to ≥3 antibiotic classes). There was no consistent pattern of resistance in serial isolates from patients.

Pulse field gel electrophoresis typing {#sec017}
--------------------------------------

PFGE typing of 270 isolates from 32 patients resulted in the patients being assigned into four groups as shown in [Table 1](#pone.0230976.t001){ref-type="table"}. This grouping is based on the relationship of subsequent isolates to first isolates as I, R or U. Isolates (n = 108) from thirteen patients representing all the four groups (patients Y, N, R, I, J, S, V, G, O, A, AF, K and B) were further studied. The dendrograms of the isolates from these thirteen patients are given in [Fig 1](#pone.0230976.g001){ref-type="fig"} and the relationship of serial isolates are shown in [Table 2](#pone.0230976.t002){ref-type="table"}. There was better differentiation of I and R isolates by BioNumerics method than by Tenover method. Both methods differentiated U isolates similarly.

![PFGE dendrograms of thirteen patients (Y, N, R, I, J, S, V, G, O, A, AF, K, B) belonging to six groups determined by PFGE grouping.](pone.0230976.g001){#pone.0230976.g001}

10.1371/journal.pone.0230976.t002

###### Typing of serial isolates of *A*. *baumannii* colonizing the rectum of patients by PFGE, MLST and eBURST.

![](pone.0230976.t002){#pone.0230976.t002g}

  Group      Patient       Isolate no.   Date of isolation   PFGE relatedness   PFGE pulsotypeby BioNumerics method   PFGE relatedness by Tenover pulsotype   ST no.   eBurst (Clonal complex)
  ---------- ------------- ------------- ------------------- ------------------ ------------------------------------- --------------------------------------- -------- -------------------------
  **1**      **Y**         **Y1**        19-Feb-2016         FI                 1a                                    FI                                      195      CC 208
  **Y2**     23-Feb-2016   R             1b                  R                  452                                   CC 208                                           
  **Y3**     2-Mar-2016    I             1a                  I                  195                                   CC 208                                           
  **Y4**     5-Mar-2016    I             1a                  I                  195                                   CC 208                                           
  **Y5a**    9-Mar-2016    R             1c                  I                  195                                   CC 208                                           
  **Y5b**    9-Mar-2016    R             1c                  I                  195                                   CC 208                                           
  **2**      **A**         **A1**        21-Apr-2016         FI                 1a                                    FI                                      884      CC 884
  **A2**     28-Apr-2016   I             1a                  I                  884                                   CC 884                                           
  **A3**     19-May-2016   R             1b                  R                  218                                   CC 208                                           
  **A4**     22-May-2016   R             1c                  I                  218                                   CC 208                                           
  **A5a**    28-May-2016   R             1b                  R                  884                                   CC 884                                           
  **A5b**    28-May-2016   U             2                   U                  218                                   CC 208                                           
  **2**      **K**         **K1**        19-May-2015         FI                 1a                                    FI                                      218      CC 208
  **K2**     8-Jun-2015    R             1b                  I                  218                                   CC 208                                           
  **K3**     30-Jun-2015   I             1a                  I                  218                                   CC 208                                           
  **K4**     24-Jul-2015   R             1c                  I                  218                                   CC 208                                           
  **K5**     18-Sep-2015   U             2                   U                  NEW1                                  NEW1                                             
  **K6**     25-Nov-2015   U             3                   U                  368                                   CC 208                                           
  **2**      **N**         **N1**        3-Nov-2015          FI                  Ia                                   FI                                      195      CC 208
  **N2**     6-Nov-2015     R             1b                 U                  195                                   CC 208                                           
  **N3**     18-Dec-2015    I             1a                 I                  195                                   CC 208                                           
  **N4a**    12-Feb-2016    R             1c                 R                  195                                   CC 208                                           
  **N4b**    12-Feb-2016    R             1d                 R                  195                                   CC 208                                           
  **N5a**    19-Feb-2016    R             1e                 R                  195                                   CC 208                                           
  **N5b**    19-Feb-2016    R             1f                 R                  195                                   CC 208                                           
  **N6a**    23-Feb-2016    U             2a                 U                  195                                   CC 208                                           
  **N6b**    23-Feb-2016    U             2b                 U                  195                                   CC 208                                           
  **N7a**    2-Mar-2016     U             3a                 U                  195                                   CC 208                                           
  **N7b**    2-Mar-2016     U             3b                 U                  195                                   CC 208                                           
  **N8**     2-Apr-2016     U             3c                 U                  218                                   CC 208                                           
  **N9**     20-Apr-2016    U             4                  U                  218                                   CC 208                                           
  **2**      **R**         **R1**        17-Jan-2016         FI                 1a                                    FI                                      218      CC 208
  **R2**     2-Feb-2016    U             2a                  U                  884                                   CC 884                                           
  **R3a**    9-Feb-2016    R             1b                  R                  884                                   CC 884                                           
  **R3b**    9-Feb-2016    U             3                   U                  NEW2                                  NEW2                                             
  **R4**     19-Feb-2016   U             3                   U                  NEW2                                  NEW2                                             
  **R5a**    9-Mar-2016    U             4                   U                  884                                   CC 884                                           
  **R5b**    9-Mar-2016    U             4                   U                  884                                   CC 884                                           
  **R6**     12-Mar-2016   U             2b                  U                  884                                   CC 884                                           
  **2**      **S**         **S1**        6-Nov-2015          FI                 1a                                    FI                                      218      CC 208
  **S2**     16-Feb-2016   R             1b                  R                  195                                   CC 208                                           
  **S3a**    12-Mar-2016   R             1d                  R                  195                                   CC 208                                           
  **S3b**    12-Mar-2016   U             2                   U                  195                                   CC 208                                           
  **S4a**    23-Mar-2016   R             1c                  R                  195                                   CC 208                                           
  **S4b**    23-Mar-2016   R             1d                  R                  195                                   CC 208                                           
  **S5**     13-Apr-2016   U             3                   U                  195                                   CC 208                                           
  **S6**     4-May-2016    U             1d                  R                  195                                   CC 208                                           
  **2**      **AF**        **AF1**       9-Apr-2016          FI                 1a                                    FI                                      218      CC 208
  **AF2**    16-Apr-2016   R             1b                  I                  218                                   CC 208                                           
  **AF3**    27-Apr-2016   R             1c                  I                  218                                   CC 208                                           
  **AF4**    7-May-2016    I             1a                  I                  218                                   CC 208                                           
  **AF5**    11-May-2016   R             1d                  I                  218                                   CC 208                                           
  **AF6**    26-May-2016   U             2                   I                  218                                   CC 208                                           
  **3**      **B**         **B1**        31-Mar-2015         FI                 1a                                    FI                                      218      CC 208
  **B2**     3-Apr-2015    U             2                   U                  218                                   CC 208                                           
  **B3**     11-Apr-2015   R             1b                  U                  218                                   CC 208                                           
  **B4**     21-Apr-2015   U             3                   U                  218                                   CC 208                                           
  **B5**     24-Apr-2015   R             1c                  U                  218                                   CC 208                                           
  **B6**     28-Apr-2015   U             4                   U                  1208                                  CC 355                                           
  **B7**     9-May-2015    U             5                   U                  218                                   CC 208                                           
  **3**      **G**         **G1a**       28-Apr-2016         FI                 1a                                    FI                                      218      CC 208
  **G1b**    28-Apr-2016   U             2                   U                  218                                   CC 208                                           
  **G2**     1-May-2016    R             1b                  R                  218                                   CC 208                                           
  **G3a**    2-Jun-2016    R             1c                  R                  218                                   CC 208                                           
  **G3b**    2-Jun-2016    U             3                   U                  218                                   CC 208                                           
  **G4**     8-Jun-2016    U             4                   U                  218                                   CC 208                                           
  **G5a**    16-Jun-2016   R             1d                  R                  218                                   CC 208                                           
  **G5b**    16-Jun-2016   R             1e                  R                  218                                   CC 208                                           
  **G5c**    16-Jun-2016   R             1f                  R                  218                                   CC 208                                           
  **3**      **O**         **O1**        21-Aug-2015         FI                 1a                                    FI                                      1980     CC 1980
  **O2**     1-Sep-2015    R             1b                  R                  1980                                  CC 1980                                          
  **O3**     19-Oct-2015   R             1c                  U                  NEW3                                  NEW3                                             
  **O4**     27-Oct-2015   U             2a                  U                  1980                                  CC 1980                                          
  **O5**     30-Oct-2015   U             2b                  U                  1980                                  CC 1980                                          
  **O6**     6-Nov-2015    U             3                   U                  218                                   CC 208                                           
  **3**      **V**         **V1**        8-Jan-2016          FI                 1a                                    FI                                      218      CC 208
  **V2**     12-Jan-2016   R             1b                  U                  1418                                  CC 234                                           
  **V3**     22-Jan-2016   U             2                   U                  1418                                  CC 234                                           
  **V4**     26-Jan-2016   U             3                   U                  1418                                  CC 234                                           
  **V5**     2-Feb-2016    R             1c                  I                  1418                                  CC 234                                           
  **4**      **I**         **I1**        12-May-2015         FI                 1                                     FI                                      NEW4     NEW4
  **I2a**    22-May-2015   U             2                   U                  368                                   CC 208                                           
  **I2b**    22-May-2015   U             3                   U                  368                                   CC 208                                           
  **I3a**    5-Jun-2015    U             4                   U                  368                                   CC 208                                           
  **I3b**    5-Jun-2015    U             5a                  U                  368                                   CC 208                                           
  **I4**     4-Sep-2015    U             5b                  U                  218                                   CC 208                                           
  **I5**     13-Oct-2015   U             5c                  U                  218                                   CC 208                                           
  **I6**     17-Nov-2015   U             6a                  U                  884                                   CC 884                                           
  **I7a**    19-Feb-2016   U             7                   U                  884                                   CC 884                                           
  **I7b**    19-Feb-2016   U             6b                  U                  884                                   CC 884                                           
  **I8**     9-Mar-2016    U             5d                  U                  195                                   CC208                                            
  **I9**     20-Apr-2016   U             6c                  U                  884                                   CC884                                            
  **4**      **J**         **J1**        22-May-2015         FI                 1                                     FI                                      218      CC 208
  **J2**     2-Jun-2015    U             2a                  U                  218                                   CC 208                                           
  **J3a**    26-Jun-2015   U             3a                  U                  218                                   CC 208                                           
  **J3b**    26-Jun-2015   U             3b                  U                  218                                   CC 208                                           
  **J4a**    3-Jul-2015    U             4a                  U                  218                                   CC 208                                           
  **J4b**    3-Jul-2015    U             4b                  U                  218                                   CC 208                                           
  **J5**     17-Jul-2015   U             3c                  U                  NEW5                                  NEW5                                             
  **J6**     19-Sep-2015   U             3d                  U                  NEW5                                  NEW5                                             
  **J7**     30-Oct-2015   U             4c                  U                  NEW5                                  NEW5                                             
  **J8**     13-Nov-2015   U             5                   U                  NEW5                                  NEW5                                             
  **J9**     18-Dec-2015   U             6                   U                  NEW6                                  NEW6                                             
  **J10a**   16-Feb-2016   U             2b                  U                  NEW6                                  NEW6                                             
  **J10b**   16-Feb-2016   U             2c                  U                  NEW6                                  NEW6                                             
  **J11**    30-Mar-2016   U             3c                  U                  NEW6                                  NEW6                                             
  **J12a**   2-Apr-2016    U             7a                  U                  NEW6                                  NEW6                                             
  **J12b**   2-Apr-2016    U             7b                  U                  NEW6                                  NEW6                                             

FI is first isolate; the relationship of first isolate to subsequent isolates are I identical, R related or U unrelated; ST no: Sequence type number; CC clonal complex., NEW is new sequence type

Multi-locus sequence typing {#sec018}
---------------------------

The analysis of serial isolates by MLST showed different patterns. There was a single ST in patients G and AF; two STs in patients B, A, V, S, N and Y; a single ST and two novel STs in patient J; two STs and a novel ST in patients O, R and K; and four STs and a novel ST in patient I. The rank order of prevalence of STs were: 42 isolates of ST218, 24 isolates of ST195, 12 isolates of ST884, 6 isolates of novel ST NEW4, 5 isolates of ST368, 4 isolates each of ST1418, ST1980 and novel ST NEW3, 2 isolates of novel ST NEW1, and one isolate each of ST452, ST1208, and novel STs, NEW2, NEW5 and NEW6.

Novel STs, NEW1 to NEW4 had new allele combinations not described in the Oxford scheme. These are shown in [S3 Table](#pone.0230976.s003){ref-type="supplementary-material"}. Novel ST, NEW3 in patient O had the following alleles: *gltA*(1), *gyrB* (17), *gdhB*(139), *recA*(12), *cpn60* (had a new sequence \[[S2 Fig](#pone.0230976.s005){ref-type="supplementary-material"}\]), *gpi*(170), *rpoD*(5). Novel ST, NEW1 in patient K had the following alleles: *gltA*(21), *gyrB*(15), *gdhB*(139), *recA*(12), *cpn60*(23), *gpi* (could not be sequenced by Sanger sequencing due to lack of binding of forward primer, but sequence obtained by Illumina sequencing, see [S3 Fig](#pone.0230976.s006){ref-type="supplementary-material"}), *rpoD* (4). All these new MLSTs were uploaded onto the Oxford MLST server.

Clonal complex determination {#sec019}
----------------------------

eBURST analysis of 108 isolates from the thirteen patients is shown [Table 2](#pone.0230976.t002){ref-type="table"} and in Figs [2](#pone.0230976.g002){ref-type="fig"} and [3](#pone.0230976.g003){ref-type="fig"}. The clonal complex (CCs) were CC208, CC234, CC355, and CC884. The singleton isolates were CC1980, and NEW1 to NEW6.

![eBURST diagram generated with MLST data representing the phylogenic relatedness of the seven *A*. *baumannii* ST types (195, 452, 218,368, 884,1208 and 1418).\
ST208, ST884, ST355 and ST234 are the clonal complex origins of CC208, CC234, CC884 and CC355, and the STs close to them differed by a single locus sequence type. Isolates further away have a double or more locus sequence type differences. Seven STs (1980 and 6 novel sequence types) from our study are not shown because they are singletons.](pone.0230976.g002){#pone.0230976.g002}

![eBURST diagram generated with MLST data representing phylogenic relatedness of the five major clonal complexes (CC208, CC234, CC884, CC355, CC1980) of *A*. *baumannii*.](pone.0230976.g003){#pone.0230976.g003}

Comparison of isolates by PFGE, ST and CC {#sec020}
-----------------------------------------

Comparison of differentiation of the isolates by the three typing methods is shown in [Table 2](#pone.0230976.t002){ref-type="table"}.

In general, there were more pulsotypes and subtypes by PFGE compared to less number of STs and CCs in all patients. As examples, patient J was colonized by 7 major BioNumerics pulsotypes with 4 pulsotypes showing 3, 4, 3 and 2 subtypes respectively. These isolates belonged to 3 STs and 3 CCs. Patient S was colonized by 3 major BioNumerics pulsotypes with 1 pulsotype showing 4 subtypes. These pulsotypes were represented by 2 STs and 1 CC. These types of better differentiation by pulsotypes can be seen in other patients.

Discussion {#sec021}
==========

DiversiLab typing was used to ascertain the genetic relationship of colony morphotypes. Our study on 12 patients showed that colonies exhibiting similar morphologies were identical genetically, and colonies of different morphologies differed genetically. Based on these observations, the number of colonies picked for the study of the 32 patients who had serial rectal samples studied, depended on the number of colony morphotypes, that is, one colony representing each morphotype was studied. We chose DiversiLab typing for the study of colony morphotypes because it is an automated method and easier than PFGE. Previous studies have demonstrated that there is a high degree of correlation between DiversiLab typing and PFGE \[[@pone.0230976.ref033]\].

By simply defining the relationship of the first isolate to the subsequent isolates as I, R or U in PFGE typing, we could assign 32 patients into 4 different groups ([Table 1](#pone.0230976.t001){ref-type="table"}). One or five patients from each group were chosen for the current study. Further analysis of PFGE results into pulsotypes, showed the following grouping of patients: colonization with identical and related isolates (patient Y), colonization with identical, related and unrelated isolates (patients N, R, S, A, AF and K), and colonization with related and unrelated isolates (patients G, J, V, O, B and I). It is tempting to conclude that related isolates may have evolved from an initial isolate that has undergone independent mutation by itself or by genetic exchange with other strains. This is a possibility as *A*. *baumannii* has a highly plastic genome and is promiscuous in exchange of genetic materials \[[@pone.0230976.ref034]\]. It is conceivable that unrelated isolates represent independent isolates. Also, the automated BioNumerics pulsotyping has better discrimination than the manual Tenover pulsotyping.

There was less variability among isolates when typed by MLST or eBURST. There were eight STs that were detected in our study, ST218, ST195, ST1208, ST1980, ST452, ST368, ST1418 and ST884. For NEW1 isolate, no amplified product for *gpi* was obtained. This is due to lack of priming of the forward primer ([S3 Fig](#pone.0230976.s006){ref-type="supplementary-material"}). Others have previously noted a similar problem with Oxford MLST scheme \[[@pone.0230976.ref035],[@pone.0230976.ref036]\]. By CC analysis, most of the isolates belonged to one type, CC208. In addition, there were singletons: ST1980 and those representing the six new STs. Our findings are supported by previous studies that have shown that PFGE typing is more discriminatory than MLST typing or eBURST analysis \[[@pone.0230976.ref037]\].

It is worth comparing the STs in our study with those from other studies in the region. In an Iranian study \[[@pone.0230976.ref038]\], the STs were 195, 387, 451, 460 and 848. In a study from Saudi Arabia, eight different STs-- 195, 208, 218, 222, 231, 286, 499 and 557- were obtained. In a multicenter study covering the Gulf Cooperation Council (GCC) countries- Saudi Arabia, United Arab Emirates, Sultanate of Oman, Qatar, Bahrain, and Kuwait \[[@pone.0230976.ref039]\]---seven different STs (195, 208, 229, 436, 450, 452 and 499) and three novel STs were seen. One or two out of eight STs obtained in our study-- 195, 218- were present in studies in Iran, Saudi Arabia or GCC countries. Our experience suggests that PFGE typing is a better discriminatory method which is suited for investigation of outbreaks in a hospital, but for inter-country comparison of isolates, STs are suitable even though MLST is less discriminatory.

There are some limitations in our study. First, with regard to isolation of *A*. *baumannii*, we enriched the rectal swabs in a liquid medium and then subcultured onto a selective agar. It is possible that this procedure might have selected out some strains, but not others. Therefore, the isolation method may not reveal the true picture of colonizing strains. Second, we did not compare the colonizing strains among patients to find out transmission of certain strains between patients. We did not deliberately do this type of comparison as the primary purpose of our study was to characterize the serial isolates colonizing individual patients. Our study was not intended to gauge transmission between patients from the standpoint of infection control.

Conclusions {#sec022}
===========

Our data suggested that serial colonization of rectum may be due to an initial isolate that has undergone mutation or colonization by independent isolates or a combination of both. Further insight into the origin of isolates colonizing this group of patients in long-stay high dependency units could be obtained by whole-genome sequencing and bioinformatics analysis.

Supporting information {#sec023}
======================

###### The relationship of colonies by DiversiLab dendrograms among similar and different morphotypes.

(DOCX)

###### 

Click here for additional data file.

###### Antimicrobial susceptibilities of 108 serial rectal *A*. *baumannii* isolates from 13 patients.

(DOCX)

###### 

Click here for additional data file.

###### Combination of gene alleles for novel MLSTs.

(DOCX)

###### 

Click here for additional data file.

###### The relationship of colonies of similar and different colony morphotypes by DiversiLab dendrogram.

Patients 1, 5 and 7 each had similar colony morphotypes. Three colonies each from these patients were genetically identical by DiversiLab. Patients 3, 6 and 8 had 3, 4 and 6 colony morphotypes, respectively. DiversiLab analysis of these colonies showed different genetic types.

(TIF)

###### 

Click here for additional data file.

###### Novel *cpn60* allele and genome sequence based MLST type for the Oxford scheme from isolate O3 (designated as NEW3) (fasta file).

(TIF)

###### 

Click here for additional data file.

###### *gpi* sequence of *A*. *baumannii* isolate K5 (designated as NEW4) showing lack of binding of forward primer.

(TIF)

###### 

Click here for additional data file.

The authors are grateful to Dieter Bulach, Peter Doherty Institute for Infection and Immunity, the University of Melbourne, Australia, for help with bioinformatics of whole genome sequence.
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Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The manuscript describes the molecular typing analysis of Acinetobacter baumannii isolates from a Kuwaitian hospital. It is well written in most parts and could be interesting for the readers of PLOS One. However, due to undeniable weaknesses in methodological procedures and data interpretation, it can not be accepted for publication in its current form.

Major comments:

\- the introduction is overlong and should be shortened. This can easily done by a less detailed explanation of the different typing methods.

\- the material and methods part is overlong and could easily be shortened by using citations (e.g. description of MLST).

\- line 50: nowadays, I would not agree that PFGE is still the gold standard. Since NGS-based typing has become widespread in many countries and as this technique has a at least equivalent or in most cases higher discriminatory power, it should be named as the gold standard. However, no consensus criteria for e.g. cgMLST exist, what is the advantage of PFGE (Tenover criteria).

\- line 52: This is not correct. PFGE has a high discriminatory power, even for isolates from different geographic regions. The real problem is, that PFGE results are not comparable from one laboratory to another due to technical variations. But one single laboratory could easily compare isolates from different regions. This has to be changed.

\- the authors did not use the Tenover criteria for outbreak investigation by PFGE. I of course know that the Tenover criteria should be used only for isolates within defined time periods, but it would be interesting to know if and how the results change when interpreted with these consensus criteria. This must be done.

\- the band patterns shown in figure 1 are of extremely low quality for some isolates that in my oppinion do not allow a reliable data interpretation. e.g. the band pattern isolate Y5a is completely unuseable due to crooked bands. When looking at the bands in detail, for me it does not look like this is another pulsotype than Y5b. Additionally, the DNA amounts seem to be very different for different isolates, which complicates the analysis even more.

The same is the case for isolates R1, R3a, J11, V2 and others\... The authors should reperform the PFGE for isolates with poor band patterns.

\- table 2: prior to publication, the new MLSTs and CCs must be numbered in coordination with the A. baumannii MLST website.

Minor comments:

\- line 44: delete \"typing of the isolates to determine their relatedness\" as this makes no sense here and seems to be a copy-paste issue

\- lines 117/118: \"%\" is missing for some numbers

\- line 121: change it to \"cultures\...were typed by PFGE.\"

\- line 188: \"eBU_R\_ST\"

Reviewer \#2: Al-Hashem et al. present results of a molecular surveillance study on Acinetobacter baumannii on an adult intensive care unit in a tertiary care centre in Kuwait. The study was conducted in a setting where A. baumannii is endemic from March 2016 to June 2017.

The surveillance was based on rectal colonization. From each specimen isolates with different morphotypes were picked and subsequently genotyped. In a pilot study the authors analyzed the association of morphotype and genotype in 12 patients. Analyses were performed with DiversiLab. Based on the pilot study data, the authors concluded that each morphotype represents one genotype.

Rectal colonization with A. baumannii was studied in 493 patients. In 73 out of 493 patients A. baumannii was detected after 72 h of admission. 32 out of theses 73 patients were positive on more than five occasions (serial isolates). Only patients with hospital-acquired (\> 72 h after admission) and with serial isolates were included. The authors grouped these 32 patients in six groups based on the "colonization pattern" and picked 13 patients (2-3 from each group, 108 isolates) for further genotypic analysis (PFGE, MLST, eBURST).

The key message is the high diversity of hospital-acquired A. baumannii strains within one patient.

Although the authors did not use whole genome sequencing for genotyping they show with several other methods (PFGE, MLST) that patients are colonized with several different strains at single time points and during hospitalization (overtime).

The article is well-written and easy to understand. Nevertheless, there are several aspects that reduce the scientific impact of this manuscript:

Major revisions

1\. The authors do not mention any antibiotic susceptibility data. I recommend adding this data as it is of interest to the reader if patients are colonized with MDR or susceptible strains.

2\. The authors compared isolates from one patient and not between the patients in the genotyping analysis. From an infections control perspective it is important to know if there were any transmissions between the patients. Transmissions can be suspected if two patients hospitalized at the same time on the same ward acquired isolates with the same pulsotype/MLST-type (person-to-person- transmission). Environment-to-patient transmissions are more difficult to prove, especially retrospectively, however A. baumannii is known to colonize the environment. For example, PFGE patterns of isolates N3 and Y4 look similar and both patients were hospitalized during the same time period (end of 2016 and beginning of 2017). Please explain, why you decided not to compare isolates of different patients and mention it in the text (limitations?).

3\. The discussion is short. Please mention more aspects (epidemiology, are there similar MLST types in the region, consequences for IPC outbreak control and typing etc.).

No limitations are mentioned. One limitation is that the sensitivity and specificity of the microbiological sampling method to detect A. baumannii is not known. Patients may still be colonized by the first strain overtime even if it is not detected.

4\. Line 90 "There was no outbreak during the study period." Please explain. What kind of outbreak do you mean? Outbreaks with any kind of bacteria or A. baumannii? Is there any active surveillance system in place to come to this conclusion? Please, mention in the text.

5\. Isolates were considered as identical (100%), related (99-80%) or unrelated (\<80%) in the PFGE analysis (Line 137-140). In my opinion, this is a very conservative approach. Even if you run the same isolate on one gel in several lanes you do not necessarily get 100% similarity. I would suggest: 100-97.5% (highly related), 97.5-80% related, \<80% unrelated. You also chose a less conservative approach in the DiversLab analysis.

6\. Table 1 is part of the results and not part of the methods. Table 1 shows the different groups based on colonization patterns of the patients overtime (identical, related, unrelated isolates). The six groups are complex and difficult to understand.

For example, Patient N is in group 1 "The first isolate disappears and is replaced by an identical or related isolate over time". However, in my opinion, patient N belongs to group 3 "the first isolate disappears and is replaced by related and unrelated isolates" as there is a relatedness of "FI, -\> R-\> I -\> R-\> U".

A better and more practical subgrouping is proposed in the discussion (line 278-280): "colonization with identical and related isolates (patient Y), colonization with identical, related and unrelated isolates (patients N, R, S, A, AF and K), and colonization with related and unrelated isolates (patients G, J, V, O, B and I).".

This is the key message of the manuscript. One must consider that patients are colonized with several geno- and phenotypes over time, which is important to know in outbreak situations and to important to trace transmissions. In an outbreak you have to include several isolates from each patient in the genotyping analysis.

7\. Whole genome sequencing (line 180-185): Please mention how many isolates and which isolates were analyzed by WGS and why.

8\. 493 patients were screened over a period of 16 months. Please mention how many patients were excluded from the study and why (no consent?). I imagine that during the period more patients than 493 were admitted on the ICU.

9\. Why did you exclude patients with A. baumannii present on admission (line 218)? Please explain.

Minor revisions

Line 42 -- 44: Please rephrase. "This organism has the propensity for acquiring multiple resistance genes with phenotypic expression of multidrug-resistant (MDR) characteristics. MDR strains are now endemic in many hospitals around the world, including hospitals in Kuwait \[3,4\] typing of the isolates to determine their relatedness."

Line 47 \[6\] Consider to mention a study where RAPD was used for A. baumannii.

Line 68. Please mention recent publications where WGS was used for A. baumannii. There are also several recent publications where a cgMLST scheme was established and used for A. baumannii.

Lines 117 -- 118: Add %.

Line 125 "v/v sarkosyl, pH 7.5)," Remove the bracket.

Line 178: Please mention the website.

Line 200 -- 203: Please shift to methods.

Line 245 "These are shown Table S2". Please rephrase

Line 244 Please mention in the results section that the new MLST types were uploaded to the MLST server and not in the discussion section (lines 288-289).

Lines 466-474: How many isolates were included in Figure 2 and Figure 3. Please mention in the text.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).
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Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]
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11/2/2020

Dear Dr. Crivelleri:

Re: PONE-D-19-35790 entitled "Genetic relatedness of serial rectal isolates of Acinetobacter baumannii in an adult intensive care unit of a tertiary hospital in Kuwait"

Thank you for forwarding the reviewers' comments and your comments. My responses are as below.

ACADEMIC EDITOR:

• Dear Authors, I was in doubt for my decision, because there are many criticisms to correct.

• There are conflicts between the reviews, actually I think the reviewers are expressing the same concepts; the weak statistical method doesn\'t permit this manuscript to be accepted as it is. It needs a very accurate revision to be published.

• Please shorten introduction, materials and methods. Answer to all the criticism moved by the reviewers in order to make the manuscript ready for publication.

Thank you for your decision to invite a revised manuscript in spite of many comments from the reviewers. We have made extraordinary efforts to answer the comments including shortening the Introduction and Materials & Methods.

Reviewer \#1:

The manuscript describes the molecular typing analysis of Acinetobacter baumannii isolates from a Kuwaitian hospital. It is well written in most parts and could be interesting for the readers of PLOS One. However, due to undeniable weaknesses in methodological procedures and data interpretation, it cannot be accepted for publication in its current form.

Major comments:

\- the introduction is overlong and should be shortened. This can be easily done by a less detailed explanation of the different typing methods.

Introduction is much shortened now (L39-L74).

\- the material and methods part is overlong and could easily be shortened by using citations (e.g. description of MLST).

Materials and Methods section is much shortened now (L76-L157).

\- line 50: nowadays, I would not agree that PFGE is still the gold standard. Since NGS-based typing has become widespread in many countries and as this technique has a at least equivalent or in most cases higher discriminatory power, it should be named as the gold standard. However, no consensus criteria for e.g. cgMLST exist, what is the advantage of PFGE (Tenover criteria).

This statement is modified now (L50).

\- line 52: This is not correct. PFGE has a high discriminatory power, even for isolates from different geographic regions. The real problem is, that PFGE results are not comparable from one laboratory to another due to technical variations. But one single laboratory could easily compare isolates from different regions. This has to be changed.

This statement is changed now (L50-L52).

\- the authors did not use the Tenover criteria for outbreak investigation by PFGE. I of course know that the Tenover criteria should be used only for isolates within defined time periods, but it would be interesting to know if and how the results change when interpreted with these consensus criteria. This must be done.

We did not investigate outbreak in our study. However, we used Tenover criteria, in addition, to interpret the relatedness of isolates (L119-L120; Table 2; L196-L197; L258-L260).

\- the band patterns shown in figure 1 are of extremely low quality for some isolates that in my opinion do not allow a reliable data interpretation. e.g. the band pattern isolate Y5a is completely unusable due to crooked bands. When looking at the bands in detail, for me it does not look like this is another pulsotype than Y5b. Additionally, the DNA amounts seem to be very different for different isolates, which complicates the analysis even more.

The same is the case for isolates R1, R3a, J11, V2 and others\... The authors should reperform the PFGE for isolates with poor band patterns.

We have repeated PFGE of these isolates several times to improve the quality of gels. What we have presented are the best patterns we have. I am afraid redoing the gels is not going to change the quality of gels or conclusions. For Y5a, even though the middle of the band is a bit drawn up, the pattern is readable. There is a misunderstanding here. We agree that Y5a and Y5b are of the same pulsotype (1c in Table 2). With regard to R1 and R3a, they are clearly different with R3a having an additional band at the top. In Table 2, these isolates are correctly labelled as 1a and 1b.

\- table 2: prior to publication, the new MLSTs and CCs must be numbered in coordination with the A. baumannii MLST website.

Unfortunately, in spite of repeated reminders, we have not heard from the curator of the Oxford MLST scheme. Colleagues in Australia and the UK too have complained of a lack of response. Important thing is that we have presented detailed information on the novel STs. If the manuscript is accepted for publication in PLOS ONE, we will communicate the new information to the journal as and when it becomes available.

Minor comments:

\- line 44: delete \"typing of the isolates to determine their relatedness\" as this makes no sense here and seems to be a copy-paste issue

Sorry for the mistake. True, it was a copy-paste issue. The sentence is deleted now (L44).

\- lines 117/118: \"%\" is missing for some numbers

\- line 121: change it to \"cultures\...were typed by PFGE.\"

Texts containing these lines are deleted while shortening the Introduction, and Materials & Methods.

\- line 188: \"eBU_R\_ST\"

The spelling mistake is corrected now (L155).

Reviewer \#2: Al-Hashem et al. present results of a molecular surveillance study on Acinetobacter baumannii on an adult intensive care unit in a tertiary care centre in Kuwait. The study was conducted in a setting where A. baumannii is endemic from March 2016 to June 2017.

The surveillance was based on rectal colonization. From each specimen isolates with different morphotypes were picked and subsequently genotyped. In a pilot study the authors analyzed the association of morphotype and genotype in 12 patients. Analyses were performed with DiversiLab. Based on the pilot study data, the authors concluded that each morphotype represents one genotype.

Rectal colonization with A. baumannii was studied in 493 patients. In 73 out of 493 patients A. baumannii was detected after 72 h of admission. 32 out of theses 73 patients were positive on more than five occasions (serial isolates). Only patients with hospital-acquired (\> 72 h after admission) and with serial isolates were included. The authors grouped these 32 patients in six groups based on the "colonization pattern" and picked 13 patients (2-3 from each group, 108 isolates) for further genotypic analysis (PFGE, MLST, eBURST).

The key message is the high diversity of hospital-acquired A. baumannii strains within one patient.

Although the authors did not use whole genome sequencing for genotyping they show with several other methods (PFGE, MLST) that patients are colonized with several different strains at single time points and during hospitalization (overtime).

The article is well-written and easy to understand. Nevertheless, there are several aspects that reduce the scientific impact of this manuscript:

Major revisions

1\. The authors do not mention any antibiotic susceptibility data. I recommend adding this data as it is of interest to the reader if patients are colonized with MDR or susceptible strains.

Susceptibility data are now added (L96-L101; L185-L188).

2\. The authors compared isolates from one patient and not between the patients in the genotyping analysis. From an infections control perspective, it is important to know if there were any transmissions between the patients. Transmissions can be suspected if two patients hospitalized at the same time on the same ward acquired isolates with the same pulsotype/MLST-type (person-to-person- transmission). Environment-to-patient transmissions are more difficult to prove, especially retrospectively, however A. baumannii is known to colonize the environment. For example, PFGE patterns of isolates N3 and Y4 look similar and both patients were hospitalized during the same time period (end of 2016 and beginning of 2017). Please explain, why you decided not to compare isolates of different patients and mention it in the text (limitations?).

This is addressed (L284-L288).

3\. The discussion is short. Please mention more aspects (epidemiology, are there similar MLST types in the region, consequences for IPC outbreak control and typing etc.).

This is now done (L271-L280).

No limitations are mentioned. One limitation is that the sensitivity and specificity of the microbiological sampling method to detect A. baumannii is not known. Patients may still be colonized by the first strain overtime even if it is not detected.

Limitations are mentioned now (L281-L288).

4\. Line 90 "There was no outbreak during the study period." Please explain. What kind of outbreak do you mean? Outbreaks with any kind of bacteria or A. baumannii? Is there any active surveillance system in place to come to this conclusion? Please, mention in the text.

Sorry, this statement was included inadvertently. There is no active surveillance, but if there is a suspicion of outbreak due to any bacteria, then, investigation is carried out.That way, there was no separate investigation during our study period.

5\. Isolates were considered as identical (100%), related (99-80%) or unrelated (\<80%) in the PFGE analysis (Line 137-140). In my opinion, this is a very conservative approach. Even if you run the same isolate on one gel in several lanes you do not necessarily get 100% similarity. I would suggest: 100-97.5% (highly related), 97.5-80% related, \<80% unrelated. You also chose a less conservative approach in the DiversLab analysis.

Because of the nature of the question asked in the study, it was necessary to adopt conservative criteria for PFGE analysis. It was a different question with regard to DiversiLab analysis. Therefore, I am afraid, the adopted approaches are justified.

6\. Table 1 is part of the results and not part of the methods. Table 1 shows the different groups based on colonization patterns of the patients overtime (identical, related, unrelated isolates). The six groups are complex and difficult to understand.

For example, Patient N is in group 1 "The first isolate disappears and is replaced by an identical or related isolate over time". However, in my opinion, patient N belongs to group 3 "the first isolate disappears and is replaced by related and unrelated isolates" as there is a relatedness of "FI, -\> R-\> I -\> R-\> U".

A better and more practical subgrouping is proposed in the discussion (line 278-280): "colonization with identical and related isolates (patient Y), colonization with identical, related and unrelated isolates (patients N, R, S, A, AF and K), and colonization with related and unrelated isolates (patients G, J, V, O, B and I).".

This is the key message of the manuscript. One must consider that patients are colonized with several geno- and phenotypes over time, which is important to know in outbreak situations and to important to trace transmissions. In an outbreak you have to include several isolates from each patient in the genotyping analysis.

We agree with this excellent suggestion and changed the grouping of patients (Table 1in Results; L199-L201).

7\. Whole genome sequencing (line 180-185): Please mention how many isolates and which isolates were analyzed by WGS and why.

This is now mentioned (L149-L151).

8\. 493 patients were screened over a period of 16 months. Please mention how many patients were excluded from the study and why (no consent?). I imagine that during the period more patients than 493 were admitted on the ICU.

We included all patients.

9\. Why did you exclude patients with A. baumannii present on admission (line 218)? Please explain.

This is now explained (L180-L182).

Minor revisions

Line 42 -- 44: Please rephrase. "This organism has the propensity for acquiring multiple resistance genes with phenotypic expression of multidrug-resistant (MDR) characteristics. MDR strains are now endemic in many hospitals around the world, including hospitals in Kuwait \[3,4\] typing of the isolates to determine their relatedness."

Sorry for the mistake. The last line was inadvertently introduced by mistake while cutting and pasting. It is now deleted (L42).

Line 47 \[6\] Consider to mention a study where RAPD was used for A. baumannii.

Reference 6 is now for A. baumannii.

Line 68. Please mention recent publications where WGS was used for A. baumannii. There are also several recent publications where a cgMLST scheme was established and used for A. baumannii.

Now reference 18 is appropriate (L58).

Lines 117 -- 118: Add %.

Line 125 "v/v sarkosyl, pH 7.5)," Remove the bracket.

These are deleted while shortening the Methods section.

Line 178: Please mention the website.

Now mentioned (L141).

Line 200 -- 203: Please shift to methods.

Done (L104-L106)).

Line 245 "These are shown Table S2". Please rephrase

Done (L166, now Table S1).

Line 244 Please mention in the results section that the new MLST types were uploaded to the MLST server and not in the discussion section (lines 288-289).

Done (L222-L223).

Lines 466-474: How many isolates were included in Figure 2 and Figure 3. Please mention in the text.

The numbers are not relevant. The figures are constructed based on sequence types.

I hope that I have answered all comments satisfactorily.

With kind regards

Yours sincerely

Professor M. John Albert

Department of Microbiology

Faculty of Medicine

Kuwait University

Kuwait
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